<html lang="en">

<head>
    <title>Pediatric Anaphylaxis</title>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width,initial-scale=1.0" />
    <link rel="stylesheet" href="cpgPedEr.css" />

</head>

<body>
    <div id="header-container"></div>
    <header class="page-header">Pediatric Anaphylaxis</header>


    <div class="container">
        <p class="cpg-headers">Definition:</p>
        <p>Rapid-onset (minutes to hours) usually immunoglobulin E (IgE)-mediated systemic allergic reaction involving
            multiple organ systems, including two or more of the following:</p>
        <ul>
            <li><strong>Cutaneous/mucosal (80% to 90%):</strong> flushing, urticaria, pruritis, angioedema</li>
            <li><strong>Respiratory (70%):</strong> laryngeal edema, bronchospasm, dyspnea, wheezing, stridor, hypoxemia
            </li>
            <li><strong>Gastrointestinal (45%):</strong> vomiting, diarrhea, nausea, crampy abdominal pain</li>
            <li><strong>Circulatory (45%):</strong> tachycardia, hypotension, syncope</li>
        </ul>

        <div class="border-btm"></div>
        <p class="cpg-headers">Management:</p>
        <ul>
            <li><strong>Stop exposure</strong> to precipitating antigens.</li>
            <li>While performing A-B-Cs, immediately give intramuscular (IM) <strong>epinephrine</strong> into the
                mid-anterolateral thigh.
                <ul>
                    <li>For a child, administer <strong>01 mg/kg of 1 mg/mL</strong> solution up to a max dose of 1
                        mg/dose.</li>
                    <li>For adult-sized patients, first administer <strong>2 to 0.5 mg of 1 mg/mL</strong> solution,
                        increasing as necessary up to a max single dose of 1 mg.</li>
                </ul>
            </li>
            <li><strong>Autoinjector dosing: </strong>
                <ul>
                    <li>5 to &lt;15 kg use 0.1 mg,</li>
                    <li>15 to &lt;30 kg use 0.15 mg,</li>
                    <li>&ge;30 kg use 0.3 mg.</li>
                </ul>
            </li>
            <li>Repeat dosing every 5 to 15 minutes as needed.</li>
            <li>Provide oxygen and ventilatory assistance. Consider early endotracheal intubation.</li>
            <li>Obtain IV access.</li>
            <li>For management of shock, resuscitate with 20 mL/ kg isotonic crystalloid fluid boluses and vasoactive
                agents as needed.</li>
            <li>Place the patient in Trendelenburg position (head 30 degrees below feet).</li>
            <li>Consider adjuvant pharmacologic agents:
                <ul>
                    <li><strong>Histamine receptor antagonist:</strong> Diphenhydramine (H1-antagonism) and famotidine
                        (H2-antagonism)</li>
                    <li><strong>Corticosteroid:</strong> Methylprednisolone or dexamethasone</li>
                    <li><strong>Inhaled &beta;2 agonist:</strong> Albuterol</li>
                </ul>
            </li>
            <li>Symptoms may recur (&ldquo;biphasic anaphylaxis&rdquo;) up to 72 hours after initial recovery.
                <ul>
                    <li>Observe for a minimum of 4 to 10 hours for late-phase symptoms.</li>
                </ul>
            </li>
            <li>Discharge with an epinephrine autoinjector and an anaphylaxis action plan.</li>
        </ul>

    </div>
    <script src="/js/header.js"></script>
</body>

</html>